They lodged their patent rejection appeal the other day on Hep C.
As for Perimavir and the FDA, are you sure the FDA wont strangle LANI with some ridiculous trial design????
I suspect some people may be cautious, even though we have $231M... I mean Biocryst had $245M of barda money and look where that got them...
Add to My Watchlist
What is My Watchlist?